Manganese X Energy : PureBiotic AIR® Provide Year-End Update on the Progress of Regulatory and Certification Registrations

Montréal, Québec, Canada, January 13^th, 2022, Manganese X Energy Corp. (TSXV: MN) (FSE: 9SC) (OTCQB: MNXXF) ("Manganese X", "MN", the "Company") is pleased to announce that its wholly owned subsidiary, Disruptive Battery Corp. (DBC) in conjunction with its US JV Partner, PureBioticAIR, Inc. (PureBiotic continues to advance the certification and regulatory registrations of its products. Work also progressed on the deconstruction of biofilm, which is calculated by the Center for Disease Control (CDC) to be a factor in 80 per cent of all infections. The deconstruction of biofilm reduces the risk of infection from pathogenic bacteria and viruses, including SARS-CoV-2 virus, cause of the COVID-19 Pandemic.

Current Regulatory Registrations:

The Company has employed additional resources to expedite the number of Food and Drug Administration (FDA), Environmental Protection Agency (EPA) and other registrations and certifications currently in progress. PureBiotics is also continuing to expand the Company's Trade Mark registrations to countries around the World. The Company's Trade Mark has already been granted in the Americas, Europe and China.

This important work is coordinated by the CEO of PureBiotic AIR^®, Lino G Morris, along with the Company's regulatory attorney, K. Steinman, Esq.. Mr. Steinman formerly worked for the US Government for years in Washington, DC in the regulatory field and has been the Company's legal lead in these matters for some time. Mr. Steinman handles all the domestic and international trademark registrations for the Company and has been working with both the EPA and FDA on the Company's new registrations. In Canada, the Company has also been working with Dicentra Regulatory Consultants, a highly respected Toronto based agency, initially for work with Health Canada, but who also have a great deal of expertise with the FDA. For specialized situations, the Company has several other Washington based agencies, all coordinated by Mr. Steinman to expedite our registrations.

The Company's current FDA registration for its PureBiotic^® Solution is of immediate interest because of the expected speed to completion. This specific registration will increase our market expansion opportunities and demonstrate the benefits of the Company's products. The combination of the EPA and FDA agencies in the USA, as well as for markets around the world, is of great importance to the Company and will provide a number of extremely significant factors that will be covered in a products report.

It should also be noted that several other registrations have already been obtained by the Company, including NFS approval and registration for a number of products. The NSF approval assures consumers and regulators that the certified products have been rigorously tested to comply with all standards required. In addition to other certifications and registrations normally listed on the Company's product labels, the Company also had previously won Green Seal Certification for a number of the Company's original products and with its new trademarked name will be re-certifying a number of its products as soon as its new USA production facility is in operation.

Martin Kepman, chief executive officer, commented: "We continue to evolve our misting solution for the mitigation of pathogens, including COVID-19. Research is showing positive efficacy. We are now moving towards additional certifications, including applying for FDA approval."

The company is not making any express or implied claim that it has developed a COVID-19 air management solution at this time.